Alexandra Kropotova - Mar 27, 2025 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Alexandra Kropotova
Stock symbol
SABS
Transactions as of
Mar 27, 2025
Transactions value $
$0
Form type
4
Date filed
4/1/2025, 04:19 PM
Previous filing
Dec 31, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SABS Common Stock Tax liability -1.18K -2.43% 47.2K Mar 27, 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of the Issuer's common stock ("Common Stock") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units ("RSUs").
F2 Includes 24,128 shares of Common Stock and 23,121 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended.
F3 Each RSU represents a contingent right to receive one share of Common Stock.